Immunotherapy of multiple sclerosis. - Wikidata - wikimedia - TriplyDB

Immunotherapy of multiple sclerosis.

Immunotherapy of multiple sclerosis.

http://www.wikidata.org/entity/Q54502086

about

The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.

P2860

Q41475478-3FD10E2D-20E8-4F91-84AC-66775485CDBC

P2860

Immunotherapy of multiple sclerosis.

http://www.wikidata.org/entity/Q54502086

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Immunotherapy of multiple sclerosis.

@en

type

label

Immunotherapy of multiple sclerosis.

@en

prefLabel

Immunotherapy of multiple sclerosis.

@en

P1433

Q54502086-440E8999-E2EF-44BC-97CA-43A4D71AA13A

P1476

Q54502086-919EBFFB-F7F4-48E9-B34A-995AAA6A6659

P2093

Q54502086-C49CD832-C33E-43E8-9CFA-9437A96C3FFE

P2860

Q54502086-0787AA1C-8602-44BE-B861-B0928D333939

Q54502086-1092E9D2-3D1D-4275-94D9-3AB83C20CA60

Q54502086-10A94063-08FF-4658-93ED-40358BC2000A

Q54502086-167EEEE7-8E32-4AC5-9AF2-08645C0B6D4B

Q54502086-17A46033-E97C-44C1-9CC5-803D01B47C7F

Q54502086-2749A686-3C84-4411-BB3F-68BA29E7F183

Q54502086-2970F37C-5353-4469-90D8-AFEF38ED0DDF

Q54502086-306CACD4-EE4B-4BB5-806C-1538DA367A6E

Q54502086-362CE982-78C2-43A5-A42D-68CB8BA08268

Q54502086-4130BEE5-8F15-4CA6-8BDF-B73EB94D8D64

P304

Q54502086-981C7D26-B654-45BF-93C8-15970A5FEE97

P31

Q54502086-728CF637-BCD9-4253-A044-DE9DEB003735

P356

Q54502086-BFC0E35C-C253-4BCC-B79C-35C8B2C90610

P478

Q54502086-1733C9A7-BE93-422E-814A-E5C717C46803

P50

Q54502086-B1B5BF45-9C8E-4982-B638-141D45AAD2F9

Q54502086-EF72194C-D07C-403E-9D81-F81C628366A3

P577

Q54502086-D07E0254-8076-44D6-B902-00AE2DE7E8E3

P698

Q54502086-F0426172-366D-451D-960E-2EE29148A5F4

P921

Q54502086-3AB795E3-A4B7-427F-B6B5-6F671297A817

Q54502086-EC731C51-7012-4B80-BE08-B468AF5ACF2C

P356

S092427080003266X

P1433

Acta Neuropsychiatrica

P1476

Immunotherapy of multiple sclerosis

@en

P2093

Sven G Meuth

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

Optic neuritis: A population-based study in Olrnsted County, Minnesota

Multiple sclerosis

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis.

Primary-progressive multiple sclerosis.

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

P304

27-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S092427080003266X

http://www.w3.org/2001/XMLSchema#string

P478

21 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25384864

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis